Вы искали: mast (Английский - Мальтийский)

mast cell tumours are cancerous proliferations of mast cells.
it-tumuri tal-mast cell huma proliferazzjonijiet kanċerużi tal-mast cells.

en 1495:1997lifting platforms – mast climbing work platforms
en 1495:1997lifting platforms — mast climbing work platforms(il-pjattaformi ta’ l-irfigħ – pjattaformi taxxogħol xabbata ta’ larbli)

masivet is a prescription medicine used to treat dog mast cell tumours.
masivet huwa mediċina bir-riċetta li tintuża għat-trattament ta’ tumuri tal-mast cell fil-klieb.

in certain circumstances, mast cell tumours can be life threatening for your dog.
f’ċerti ċirkustanzi, it-tumuri tal-mast cell jistgħu jkunu ta’ theddida għall-ħajja tal-kelb tiegħek.

for any mast cell tumour treatable by surgery, surgery should be the first choice of treatment.
għal kwalunkwe tumur tal-mast cell li jista’ jiġi kkurat b’kirurġija, il-kirurġija għandha tkun it- trattament tal-ewwel għażla.

there was no evidence of an anaphylactic response due to mast-cell degranulation in cynomolgus monkeys.
ma kienx hemm evidenza ta’ rispons anafilattiku permezz ta’ degranulazzjoni ta’ ċelluli tat-tip mast fix-xadini cynomolgus.

masivet is used to treat dogs with mast-cell tumours (a type of cancer).
masivet jintuża biex jikkura klieb b’tumuri taċ-ċelluli-mast (tip ta’ kanċer).

data from in vitro studies suggest that it may act on human conjunctival mast cells to inhibit the release of pro-inflammatory mediators.
minn tagħrif ta 'studji in vitro jidher li jista ’ jaħdem fuq iċ- ċelluli mast tal- konġuntiva umana biex jinibixxi sustanzi pro- infjammatorji.

as a result, they indirectly benefit fishermen by rebuilding stocks in areas closed to fishing, where mast foundations perform the function of artificial reefs.
b’mod indirett għalhekk, dawn l-installazzjonijiet jibbenefikaw lis-sajjieda peress li jibnu mill-ġdid l-istokkijiet f’dawn iż-żoni pprojbiti għas-sajd, fejn il-fondazzjonijiet tal-arbli jaġixxu bħala sikek artifiċjali.

masitinib treatment should only be used in dogs with non-resectable mast cell tumours and which express the mutated c-kit tyrosine kinase receptor.
it-trattament b’masitinib għandu jintuża biss fi klieb li jkollhom tumuri tal-mast cell li ma jkunux jistgħu jitneħħew u li jesprimu r-riċettur mibdul tal-c-kit tyrosine kinase.

iron or steel towers and lattice masts
torrijiet tal-ħadid jew l-azzar u arbli tal-kannizzati